Enriching the molecular definition of the airway "Field of cancerization:" Establishing new paradigms for the patient at risk for lung cancer

Cancer Prevention Research

Volumn 6, Issue 1, 2013, Pages 4-7

  Gomperts, Brigitte N ^a,b,d   Walser, Tonya C ^b   Spira, Avrum ^e,f,g   Dubinett, Steven M ^b,c,h  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Pathology   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^f BOSTON UNIVERSITY   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

BRONCHOSCOPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; GENE EXPRESSION; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY EPITHELIUM; REVIEW; RNA EXTRACTION;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; SMOKING;

EID: 84872707487     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-12-0470     Document Type: Review

References (22)

1. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-8.
2. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997; 100: 2133-7. (Pubitemid 27459370)
3. Gomperts BN, Spira A, Massion PP, Walser TC, Wistuba II, Minna JD, et al. Evolving concepts in lung carcinogenesis. Semin Respir Crit Care Med 2011; 32: 32-43.
4. Trujillo KA, Jones AC, Griffith JK, Bisoffi M. Markers of field cancerization: proposed clinical applications in prostate biopsies. Prostate Cancer 2012; 2012:302894.
5. Angadi PV, Savitha JK, Rao SS, Sivaranjini Y. Oral field cancerization: current evidence and future perspectives. Oral Maxillofac Surg 2012; 16: 171-80.
6. Rivenbark AG, Coleman WB. Field cancerization in mammary carcinogenesis - implications for prevention and treatment of breast cancer. Exp Mol Pathol 2012 Nov 6 [Epub ahead of print].
7. Lee YC, Wang HP, Wang CP, Ko JY, Lee JM, Chiu HM, et al. Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers. Cancer Prev Res 2011; 4: 1982-92.
8. Damania D, Roy HK, Subramanian H, Wenberg DS, Rex DK, Goldberg MJ, et al. Nanocytology of rectal colonocytes to assess risk of colon cancer based on field cancerization. Cancer Res 2012; 72: 2720-7.
9. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997; 89: 857-62. (Pubitemid 27268450)
10. Steiling K, Ryan J, Brody JS, Spira A. The field oftissue injuryinthe lung and airway. Cancer Prev Res 2008; 1: 396-403.
11. Nelson MA, Wymer J, Clements N Jr. Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers. Cancer Lett 1996; 103: 115-21. (Pubitemid 26125172)
12. Powell CA, Klares S, O'Connor G, Brody JS. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer. Clin Cancer Res 1999; 5: 2025-34. (Pubitemid 29399254)
13. Tang X, Shigematsu H, Bekele BN, Roth JA, Minna JD, Hong WK, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res 2005; 65: 7568-72. (Pubitemid 41297226)
14. Tang X, Varella-Garcia M, Xavier AC, Massarelli E, Ozburn N, Moran C, et al. Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas. Cancer Prev Res 2008; 1: 192-200.
15. Perdomo C, Spira A, Schembri F. MiRNAs as regulators of the response to inhaled environmental toxins and airway carcinogenesis. Mutat Res 2011; 717: 32-7.
16. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, Ergun A, et al. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A 2009; 106: 2319-24.
17. Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007; 13: 361-6. (Pubitemid 46376687)
18. Beane J, Sebastiani P, Whitfield TH, Steiling K, Dumas YM, Lenburg ME, et al. A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev Res 2008; 1: 56-64.
19. Bhutani M, Pathak AK, Fan YH, Liu DD, Lee JJ, Tang H, et al. Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res 2008; 1: 39-44.
20. Sridhar S, Schembri F, Zeskind J, Shah V, Gustafson AM, Steiling K, et al. Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium. BMC Genomics 2008; 9:259.
21. Kadara H, Shen L, Fujimoto J, Saintaigny P, Chow C-W, Lang W, et al. Characterizing the molecular spatial and temporal field of injury in early stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling. Cancer Prev Res 2012 Oct 19. [Epub ahead of print].
22. Gustafson AM, Soldi R, Anderlind C, Scholand MB, Qian J, Zhang X, et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med 2010; 2:26ra5.